Skip to content
healthcare.dev
Get a free key

Risedronate Sodium

NDC 65862-519, Risedronate Sodium, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
65862-519
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200296
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-519 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM35 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
65862-519-04658620519041 BLISTER PACK in 1 CARTON (65862-519-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK
65862-519-08658620519083 BLISTER PACK in 1 CARTON (65862-519-08) / 4 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/89896dfe-f69d-4cb3-bb71-7a7c611071fa

Use it

Look up 65862-519 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-519 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-519. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.